Encysive Pharmaceuticals

Endothelin receptor antagonist for the treatment of pulmonary arterial hypertension.

placeHouston, Texas, United States calendar_todayFounded 1990 groups148 employees language encysive.com

Innovation

38 patent families (19 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace dormant. Cited 339 times.

YearFilings
20128
20133
20141
20153
20161
20171

Investor mix

1 investor on record.

Investor typeCountShare
Private equity1100%
Coming soon